Cause Of Medication Error In Pediatrics Population
Contents |
Pediatrics in Review Journal CME Career Center AAP Policy Sections Login Submit Manuscript AAP Policy & Collections Alerts Subscribe aap.org Advertising Disclaimer » A statement of reaffirmation for this policy pediatric medication errors statistics was published at 119(5):1031 revised 102(2):428 A statement of retirement for this policy pediatric medication error cases was published at 128(1):e258 PediatricsAugust 2003, VOLUME 112 / ISSUE 2 Prevention of Medication Errors in the Pediatric Inpatient preventing pediatric medication errors Setting Committee on Drugs and Committee on Hospital Care Article Info & Metrics Comments Download PDF AbstractAlthough medication errors in hospitals are common, medication errors that result in death or serious injury occur pediatric medication error stories rarely. Even before the Institute of Medicine reported on medical errors in 1999, the American Academy of Pediatrics and its members had been committed to improving the health care system to provide the best and safest health care for infants, children, adolescents, and young adults. This commitment includes designing health care systems to prevent errors and emphasizing the pediatrician’s role in this system. Human and device
Preventing Pediatric Medication Errors Joint Commission
errors can lead to preventable morbidity and mortality. National and state legislative actions have heightened public awareness of these events. All involved persons, beginning with the physician and including every member of the health care team, must be better educated about and engaged in the several steps recommended to decrease these errors. The safe administration of medications to hospitalized infants and children requires additional specific safeguards that are above and beyond those for adult patients. Pediatricians should help hospitals develop effective programs for safely providing medications, reporting medication errors, and creating an environment of medication safety for all hospitalized pediatric patients.BACKGROUNDHospitalized infants and children are subject to advantages and risks of inpatient care. Included in most medical and surgical treatment regimens for hospitalized pediatric patients is administration of medications that may be associated with undesirable as well as therapeutic effects. The Institute of Medicine (IOM)1 defines an adverse drug event (ADE) as an injury resulting from medical intervention related to a drug, which can be attributable to preventable and nonpreventable causes. Of these, adverse reactions to medications include those that are usually unpredictable, such as idiosyncratic or unexpected allergic responses, and those that are pred
Know Governance Job Openings Login to PA-PSRS About PA-PSRS Data Interface Facility Reporting Information Login to PassKey About PassKey Advisory Library Patient and Consumer Tips
Pediatric Medication Safety
Press Releases Healthcare-Associated Infections Brochures Related Organization Links The Authority in preventing medication errors in pediatric and neonatal patients the News Driving Change Patient Safety Tools Calendar Public Meetings ADDRESS: Patient Safety Authority 333 Market pediatric medication administration guidelines Street Lobby Level Harrisburg, PA 17120 Phone: 717-346-0469 Fax: 717-346-1090 SearchAdvanced Search Medication Errors Affecting Pediatric Patients: Unique Challenges for This Special Population Pa Patient Saf http://pediatrics.aappublications.org/content/112/2/431 Advis 2015 Sep;12(3):96-102. Matthew Grissinger, RPh, FISMP, FASCP Manager, Medication Safety Analysis Pennsylvania Patient Safety AuthorityAbstractFrom January 2013 through October 2014, 4,065 medication errors involving pediatric patients and taking place in a general acute care hospital not specializing in pediatrics were reported to the Pennsylvania Patient Safety Authority. Almost 18% (n = 715, 17.8%) http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2015/Sep;12(3)/Pages/96.aspx of the reported events reached the patient and either required additional monitoring to preclude harm or caused actual harm. These reports were analyzed to determine if the events involved unique challenges when providing medications to the pediatric patient as well as to classify the events by node, related processes, possible causes, and contributing factors. When looking at the age ranges of patients involved in events, 28.1% (n = 201) of the reports involved neonates and 60.2% (n = 431) involved patients younger than five years of age. While there were events that included unique challenges to providing medications to the pediatric patients, most events mentioned challenges similar to those encountered in providing medications to adults. Important risk reduction strategies include dispensing medications for individual patients in a patient-specific, ready-to-administer form whenever possible and ensuring ready access to appropriate and current clinical information about patients.IntroductionThe pediatric patient population can be considered in the developmental subcategories of preterm neonates (less than 36 weeks’ gestation), ful
information and have no effect once you leave the Medscape site.